Cystic Fibrosis (CF) Therapeutics Market By Therapeutics (Mucolytics, Bronchodilators, CFTR modulators, Pancreatic enzyme supplements), By Route of Administration (Inhaled drugs, Oral drugs), Industry Trends, Estimation & Forecast, 2017 - 2025

July 2018

 Pages: 182

 ERC 7073


Cystic fibrosis therapeutics market is expected to grow with a CAGR of 16.2% during the forecast period of 2018 to 2025.

Cystic fibrosis is a chronic, progressive disease causing severe damage to the exocrine glands of body such as pancreas, liver, lungs, and intestines. It is caused by mutation in the gene Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) that alters the normal fluid and electrolyte secretion function of the secretory glands. The surging occurrence of cystic fibrosis is the major factor involved in the growth of the cystic fibrosis therapeutics market. Based on the data revealed by the Cystic Fibrosis Research Inc., more than 30,000 people in the United States have cystic fibrosis and approximately 900-1000 new cases of fatal CF arise every year. Various initiatives are being taken by the non-profit organizations and government, which is also contributing towards the market growth of cystic fibrosis therapeutics.

The commencement of beneficial programs for patients suffering from cystic fibrosis has stimulated the demand for cystic fibrosis therapeutics. For example, in 2017, a neonatal screening program for cystic fibrosis had covered most of the Brazilian states, with referral centers kept for the patient’s follow up. The high cost of the treatment procedures, unfavourable reimbursement scenario, and huge R&D investments are creating hurdles in the market growth. In the current scenario, there is no permanent cure for cystic fibrosis, however, advancements in technology has led to the advent of gene therapy, which is anticipated to change the scenario in the near future.

The report provides detailed qualitative and quantitative analysis of the cystic fibrosis therapeutics market. Market size and forecast has been provided for the period - (2018 - 2025), for the segments namely therapeutics and route of administration in each of the major regions.

Cystic Fibrosis Therapeutics Market Player Analysis -

The report presents detailed analysis of major players operating in cystic fibrosis therapeutics market. Few of them include AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc. Alcresta Therapeutics Inc., Allergan Plc., F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., AstraZeneca Plc., Alaxia, and Vertex Pharmaceuticals Inc. A detailed coverage on these market players with information on their revenue from cystic fibrosis therapeutics business, market share, gross margin and their growth strategies have been provided in the report.

Market Segmentation

Cystic fibrosis therapeutics market is segmented on the basis of therapeutics, route of administration and geography. By therapeutics, the market is segmented into mucolytics, bronchodilators, CFTR modulators, and pancreatic enzyme supplements. By route of administration, the market is categorized into inhaled drugs and oral drugs. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Cystic Fibrosis Therapeutics Market Segmentation

By Therapeutics
•    Mucolytics
•    Bronchodilators
•    CFTR modulators
•    Pancreatic enzyme supplements

By Route of Administration
•    Inhaled drugs
•    Oral drugs

By Geography
•    North America
o    U.S.
o    Canada
o    Mexico
•    Europe
o    U.K.
o    France
o    Germany
o    Italy
o    Spain
o    Rest of Europe
•    Asia-Pacific
o    China
o    Japan
o    India
o    Korea
o    Rest of APAC
•    South America
o    Brazil
o    Rest of South America
•    Rest of the World
o    Middle East
o    Africa

Cystic Fibrosis Therapeutics Market Key Players

•    AbbVie Inc.
•    Novartis AG
•    Teva Pharmaceutical Industries Ltd.
•    Merck & Co. Inc.
•    Alcresta Therapeutics Inc.
•    Allergan Plc
•    F. Hoffmann-La Roche Ltd.
•    Gilead Sciences, Inc.
•    AstraZeneca Plc
•    Alaxia
•    Vertex Pharmaceuticals Inc.

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Cystic Fibrosis Therapeutics Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Cystic Fibrosis Therapeutics Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!